Article
Post- Hoc Analysis Finds Erenumab Enables Reversion From Chronic to Episodic Migraine
Rating:
0.0
Views:
78
Likes:
1
Library:
1
The analysis, published in Cephalalgia, found that more than 50% of patients exhibited reversion from chronic migraine to episodic migraine after week 12 of the double-blind treatment phase.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value